Download Full Text (294 KB)
• The incidence of type 2 diabetes has been increasing at a rapid rate in the United States.
• Metformin is recommended as the first line treatment to be started at the time of diagnosis in all patients without contraindications and has been associated with vitamin B12 deficiency.
• There are currently no clinical guidelines for the routine monitoring of B12 levels in this population.
• The purpose of this scholarly project is to determine if there are consequences of this deficiency and to make recommendations for screening patients.
• It includes current research that focuses on the pathophysiology of a B12 deficiency, the prevalence and consequences of such a deficiency, and practices in monitoring patients for it.
• While many type 2 diabetics treated with metformin will develop a vitamin B12 deficiency, there may not be any consequences of this deficiency.
• More research is needed before universal guidelines can be established. At this point in time, monitoring B12 levels should be a decision based on individual patient’s risk factors and symptoms.
Physician Assistant Studies
Master of Physician Assistant Studies (MPAS)
Anemia -- chemically induced; Drug Monitoring; Hypoglycemic Agents -- adverse effects; Metformin -- adverse effects; Vitamin B 12 Deficiency -- complications
Endocrinology, Diabetes, and Metabolism | Pharmaceutical Preparations
Dietz, Kathryn, "Metformin and Vitamin B12 Deficiency: Consequences and Patient Monitoring" (2017). Physician Assistant Scholarly Project Posters. 37.